Depressive symptoms among people with HIV/AIDS in Northwest Ethiopia: comparative study.
Volume: 11
Issue: 7
Year of Publication: 2021
Abstract summary
The objective of this study was to compare depressive symptoms among people with HIV/AIDS and the general population sample. We also assessed the factors associated with depressive symptoms.A comparative cross-sectional study was conducted.Antiretroviral therapy clinics in three primary healthcare facilities and semi-urban area in Northwest Ethiopia.A total of 1115 participants (558 people with HIV/AIDS and 557 comparison group) aged 18 years and above were recruited. A total of 1026 participants (530 people with HIV/AIDS and 496 comparison group) completed the interview. We excluded people with known HIV-positive status from the comparison group.Patient Health Questionnaire (PHQ-9) was used to assess depressive symptoms. The proportion of depressive symptoms was compared between samples of the general population and people with HIV/AIDS using χ statistics. Multivariable logistic regression analysis was done to examine the associated factors.The overall prevalence of depressive symptoms was 13.3% (11.2%-15.4%). The prevalence was significantly higher in people with HIV/AIDS compared with the community sample (16.6% vs 12.3%), p=0.001. The difference was also significant in the multivariable logistic regression (OR 1.7). For the overall sample, depressive symptoms were significantly associated with older age, being single, divorced/widowed marital status, and poor social support.Depressive symptoms were higher in people with HIV/AIDS compared with the general population. It is necessary to include mental healthcare and screening for depression in routine HIV/AIDS care.Study Outcome
Source Link: Visit source
Statistics
Citations : GBD 2017 HIV collaborators . Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017. Lancet HIV 2019;6:e831–59. 10.1016/S2352-3018(19)30196-1Authors : 3
Identifiers
Doi : e048931SSN : 2044-6055